Over view  |  Facility  |  Vision  |  Mission  |  Chairman | Staff & Human Resources | Global Exposure


Triumpharma Founder and CEO

Dr. Al-Ghazawi is currently President and CEO of Triumpharma.

č Click here to open the PDF file

He has over 18 years of experience in the pharmaceutical sector. He has worked with Merck and GlaxoSmithKline for over seven years as a pharmaceutical scientist, later became the technical and development manager responsible for directing, designing, and development of new and existing Merck drug delivery systems (DDS). Prior to joining SmithKline he was a senior pharmaceutical scientist at Norton Healthcare for nearly 4 years and have been involved in designing and developing of a novel dry powder inhaler and breath operated inhaler that won Prince Charles's Award for Innovation in UK,1996.

Dr. Al-Ghazawi is a member of the American Association of Pharmaceutical Scientist (AAPS); USA, the Controlled Release Society Inc.; USA, the Royal Pharmaceutical Society of Great Britain – Academy of Pharmaceutical Sciences and The Aerosol Society; UK. Dr Al-Ghazawi was a visiting lecturer teaching 2/3-year pharmaceutical chemistry students for 1998-1999 courses at the University of Kent, Canterburry, UK.

Dr. Al-Ghazawi is an inventor/co-inventor of many patents in drug delivery systems. One of his patents covers Paroxetine salt, an antidepressant drug. Paxil® (Paroxetine HCl) sells at $2.2 billion in the USA annually. Dr Al-Ghazawi received his PhD from the School of Pharmacy, University of London,-UK, B.Pharm., from Jordan University of Science and Technology- Jordan and his high school Diploma from the USA.

HOME | About Us | Services | Product | Contact Us | Quotation Request